As of 3:48:57 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AI DMI ,L.L.C. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 17, 2024 | 3,558,430 |
| ASHIYA MONA Director | Purchase | Jun 17, 2024 | -- |
| BITTERMAN KEVIN J Director | Purchase | Jun 17, 2024 | -- |
| FRANCHI JEAN M Chief Financial Officer | Stock Award(Grant) | Feb 7, 2024 | 36,666 |
| KHARA RAHUL Officer | Sale | Jan 2, 2025 | 14,035 |
| ORBIMED ADVISORS, L.L.C. Director | Purchase | Jun 17, 2024 | -- |
| QUISEL JOHN D Chief Executive Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 82,065 |
| SAVAGE WILLIAM JACOB Officer | Sale | Nov 25, 2024 | 40,405 |
| STEPHENSON PAMELA Officer | Stock Award(Grant) | Feb 26, 2024 | 36,666 |
| WHITE WILLIAM RICHARD Director | Sale | Dec 2, 2024 | 0 |
Related Tickers
MURA Mural Oncology plc
3.8367
+5.12%
FDMT 4D Molecular Therapeutics, Inc.
5.44
-6.85%
PLRX Pliant Therapeutics, Inc.
12.05
-4.44%
ACLX Arcellx, Inc.
68.84
-4.73%
EWTX Edgewise Therapeutics, Inc.
24.14
-5.04%
SYRE Spyre Therapeutics, Inc.
21.89
-8.87%
DSGN Design Therapeutics, Inc.
4.5700
-9.95%
APGE Apogee Therapeutics, Inc.
40.62
-17.46%
NUVL Nuvalent, Inc.
76.57
-2.15%
ERAS Erasca, Inc.
2.4000
-12.73%